CHD Closure Devices Market Regional Analysis, Demand Analysis, and Competitive Outlook 2025–2032



Date – 06-10-2025

[ Pune , India ]

Congenital Heart Defect (CHD) Closure Devices are specialized minimally invasive medical implants used to seal abnormal openings in the heart that are present at birth. These devices play a crucial role in treating congenital cardiac conditions such as Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Ductus Arteriosus (PDA) by restoring normal blood flow between heart chambers or vessels.

Get free sample of this report at : https://www.24lifesciences.com..../download-sample/278

Typically made from biocompatible materials like nitinol (nickel-titanium alloy) and polyester fabric, CHD closure devices enable transcatheter procedures, eliminating the need for open-heart surgery. These interventions provide faster recovery, fewer complications, and reduced hospital stays, significantly improving patient outcomes in pediatric and adult cardiology.

Market Size
The Global CHD Closure Devices Market was valued at USD 252 million in 2024 and is projected to grow from USD 269 million in 2025 to USD 392 million by 2031, registering a CAGR of 6.7% during the forecast period (2025–2032).

This growth is fueled by the increasing prevalence of congenital heart defects, improved diagnostic screening, and rising demand for minimally invasive cardiac procedures. The growing number of specialized cardiac centers and government initiatives supporting early CHD detection also contribute to market expansion.

As of 2024, Abbott and Boston Scientific collectively hold over 60% of the global market share, underscoring the industry’s semi-consolidated nature and dominance of innovation-driven multinational corporations.